- Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens
-
Hyun SY, Han SH, Kim SJ, Jang JE, Kim Y, Cho H, Lee JY, Cheong JW, Min YH, Song JW, Kim JS
- KMID: 2363688
- J Korean Med Sci.
- 2016 Apr;31(4):510-518.
- doi: 10.3346/jkms.2016.31.4.510
The aim of this study was to identify the risk factors associated with severe bacterial infection (SBI) in multiple myeloma (MM) patients during treatment with bortezomib-based regimens. A total of... -
- CITED
-
- Close
- SHARE
-
- Close
